The UK consumes over 3500 kilos of #cannabis every single day. Criminal drugs markets are the principal cause of crime and violence. A #drugspolicy based on control and #regulation would reduce these problems, create jobs, free police time and generate new tax revenue.
"The illegality of cannabis is outrageous, an impediment to full utilization of a drug which helps produce the serenity and insight, sensitivity and fellowship so desperately needed in this increasingly mad and dangerous world."
Read more at: https://t.co/0L6eA8USA6
No victim. No crime.
End custodial sentences for cannabis possession.
End criminal records for the cultivation, sale and possession of cannabis entirely.
People who purposely contaminate cannabis or target children for profit you don't get a pass.
#decrininalise
A new law legalizing medical cannabis in Ukraine officially took effect, with a deputy prime minister saying the list of qualifying conditions will be expanded "so that as many patients as possible who need the necessary drugs can get access to them."
https://t.co/j9Dme96zVH
Oh Leanne you silly silly woman.
Business destroyed, credibility ruined.
ANOTHER criminal record added to your already grown record.
The humiliation of your actions.
Surprised you weren't still in your pink shorts that seem to be stitched to you.
Bravo @northumbriapol amazing work by your officers. 12 down, thousands to go though 👏👏
Comeuppance is amazing to watch.
#Riots #Sunderland #SunderlandProtest #FarRightThugs
🌿 The study's authors concluded: "The present study represents the first human clinical trial to examine the acute effects of CBG on anxiety, stress, and mood." https://t.co/K6xKZcpo6V
We’re excited to announce the UK Medical Cannabis Registry, the largest of its kind in Europe, has just reached a significant milestone with 25 peer-reviewed publications using Registry data.
We extend our heartfelt gratitude to over 20,000 patient contributors (1/2)
“Baltimore researchers find cannabis could be effective treatment Anxiety and Depressive Symtoms”
• The research, which included individuals diagnosed with clinical depression, revealed that those using medicinal cannabis reported lower depression scores compared to non-users
• Depression affects more than 300 million people globally, making it one of the most debilitating medical conditions worldwide
• The study involved 538 participants, with 368 using medical cannabis and 170 considering its use
•The study found significant differences between cannabis users and non-users:
– Depression: Participants using cannabis, especially CBD-rich products, reported lower depression levels.
– Quality of Life: Cannabis users reported higher quality of life and better sleep quality.
– Pain Management: Cannabis users experienced less pain over the past month.
– Anxiety: Initial anxiety levels did not differ significantly between users and non-users. However, those who began using cannabis during the study period showed reductions in anxiety and depression.
https://t.co/3kWreCWHj6…
https://t.co/O85kApYy5p…
We believe any patient, at any clinic, should be able to access any suitable #MedicalCannabis product – at the same price as all other patients.
This industry needs to stop fragmenting, and fighting for their own commercial interests to the detriment of patients overall.
🧠 Researchers acknowledged, "[N]either young age of onset of cannabis use nor high-frequency use of cannabis or the preferred type of cannabis was associated with cannabis-associated psychotic symptoms.” https://t.co/6dyduNAi8d
😚💨 The study's authors determined, "[B]oth depression and anxiety symptoms significantly decreased after cannabis use in general; results at the user level of analysis showed that the majority of users experienced positive relief outcomes." https://t.co/QYv9fTAgvZ